473
Views
8
CrossRef citations to date
0
Altmetric
Review Article

Chronic lung disease in common variable immune deficiency (CVID): A pathophysiological role for microbial and non-B cell immune factors

, , , , &
Pages 508-519 | Received 22 Dec 2015, Accepted 01 Dec 2016, Published online: 10 Jan 2017

References

  • Abolhassani H, Sagvand BT, Shokuhfar T, et al. (2013). A review on guidelines for management and treatment of common variable immunodeficiency. Expert Rev Clin Immunol 9:561–74. Quiz 575.
  • Agerberth B, Gudmundsson GH. (2006). Host antimicrobial defence peptides in human disease. Curr Top Microbiol Immunol 306:67–90.
  • Aghamohammadi A, Moin M, Farhoudi A, et al. (2004). Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia. FEMS Immunol Med Microbiol 40:113–18.
  • Alvarez B, Arcos J, Fernandez-Guerrero ML. (2011). Pulmonary infectious diseases in patients with primary immunodeficiency and those treated with biologic immunomodulating agents. Curr Opin Pulmonary Med 17:172–9.
  • Ardeniz O, Cunningham-Rundles C. (2009). Granulomatous disease in common variable immunodeficiency. Clin Immunol (Orlando, FL) 133:198–207.
  • Armstrong D, Grimwood K, Carlin JB, et al. (1998). Severe viral respiratory infections in infants with cystic fibrosis. Pediatric Pulmonol 26:371–9.
  • Baris S, Ercan H, Cagan HH, et al. (2011). Efficacy of intravenous immunoglobulin treatment in children with common variable immunodeficiency. J Invest Allergol Clin Immunoly: Off Organ Int Assoc Asthmol (INTERASMA) Soc Latinoam Alergia Inmunol 21:514–21.
  • Biagi F, Bianchi PI, Zilli A, et al. (2012). The significance of duodenal mucosal atrophy in patients with common variable immunodeficiency: a clinical and histopathologic study. Am J Clin Pathol 138:185–9.
  • Bolger MS, Ross DS, Jiang H, et al. (2007). Complement levels and activity in the normal and LPS-injured lung. Am J Physiol Lung Cell Mol Physiol 292:L748–59.
  • Brent J, Guzman D, Bangs C, et al. (2015). Clinical and laboratory correlates of lung disease and cancer in adults with idiopathic hypogammaglobulinemia., Clin Exp Immunol 184:73–82.
  • Capitani N, Ariani F, Amedei A, et al. (2012). Vav1 haploinsufficiency in a common variable immunodeficiency patient with defective T-cell function. Int J Immunopathol Pharmacol 25:811–17.
  • Castigli E, Wilson SA, Garibyan L, et al. (2005). TACI is mutant in common variable immunodeficiency and IgA deficiency. Nature Genetics 37:829–34.
  • Casulli S, Coignard-Biehler H, Amazzough K, et al. (2014). Defective functions of polymorphonuclear neutrophils in patients with common variable immunodeficiency. Immunol Res 60:69–76.
  • Cederlund A, Olliver M, Rekha RS, et al. (2011). Impaired release of antimicrobial peptides into nasal fluid of hyper-IgE and CVID patients. PLoS One 6:e29316.
  • Chapel H, Cunningham-Rundles C. (2009). Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 145:709–27.
  • Chase NM, Verbsky JW, Hintermeyer MK, et al. (2013). Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). J Clin Immunol 33:30–9.
  • Chen Y, Stirling RG, Paul E, et al. (2011). Longitudinal decline in lung function in patients with primary immunoglobulin deficiencies, J Allergy Clin Immunol 127:1414–17.
  • Cole PJ. (1986). Inflammation: a two-edged sword?the model of bronchiectasis. Eur J Respir Dis Suppl 147:6–15.
  • Cunningham-Rundles C. (2012). The many faces of common variable immunodeficiency. Hematol/ Educ Program Am Soc Hematol. Am Soc Hematol Educ Program 2012:301–5.
  • Cunningham-Rundles C. (2010). How I treat common variable immune deficiency. Blood 116:7–15.
  • Cunningham-Rundles C, Bodian C. (1999). Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol (Orlando, FL) 92:34–48.
  • da Silva SP, Resnick E, Lucas M, et al. (2011). Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events, J Clin Immunol 31:784–791.
  • Deane S, Selmi C, Naguwa SM, et al. (2009). Common variable immunodeficiency: etiological and treatment issues. Int Arch Allergy Immunol 150:311–24.
  • dos Santos-Valente EC, da Silva R, de Moraes-Pinto MI, et al. (2012). Assessment of nutritional status: vitamin A and zinc in patients with common variable immunodeficiency. J Invest Allergol Clin Immunol: Off Organ Int Assoc Asthmol (INTERASMA) Soc Latinoam Alergia Inmunol 22:427–31.
  • Duraisingham SS, Manson A, Grigoriadou S, et al. (2015). Immune deficiency: changing spectrum of pathogens. Clin Exp Immunol 181:267–74.
  • Edgar JD, Buckland M, Guzman D, et al. (2014). The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008–2012. Clin Exp Immunol 175:68–78.
  • Einarsson GG, Comer DM, McIlreavey L, et al. (2016). Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers. Thorax. 71:795–803.
  • Erb-Downward JR, Thompson DL, Han MK, et al. (2011). Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS One 6:e16384
  • Fasth A. (1982). Primary immunodeficiency disorders in Sweden: cases among children, 1974–1979. J Clin Immunol 2:86–92.
  • Fevang B, Mollnes TE, Holm AM, et al. (2005). Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis. Clin and Exp Immunol 142:576–84.
  • Flight WG, Bright-Thomas RJ, Tilston P, et al. (2014). Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis. Thorax 69:247–53.
  • Fodor AA, Klem ER, Gilpin DF, et al. (2012). The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS One 7:e45001.
  • Fried AJ, Bonilla FA. (2009). Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. Clin Microbiol Rev 22:396–414.
  • Ganz T. (2003). The role of antimicrobial peptides in innate immunity. Integr Comp Biol 43:300–4.
  • Garcia-Lloret M, McGhee S, Chatila TA. (2008). Immunoglobulin replacement therapy in children. Immunol Allergy Clin N Am 28:833–49. ix.
  • Giovannetti A, Pierdominici M, Mazzetta F, et al. (2007). Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol (Baltimore, MD: 1950) 178:3932–43.
  • Goldman MJ, Anderson GM, Stolzenberg ED, et al. (1997). Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553–60.
  • Goralski JL, Davis SD. (2015). Improving complex medical care while awaiting next-generation CFTR potentiators and correctors: the current pipeline of therapeutics. Pediatric Pulmonol 50:S66–S73.
  • Greer RL, Morgun A, Shulzhenko N. (2013). Bridging immunity and lipid metabolism by gut microbiota. J Allergy Clin Immunol 132:253–62. quiz 263.
  • Guggemoos S, Hangel D, Hamm S, et al. (2008). TLR9 contributes to antiviral immunity during gammaherpesvirus infection. J Immunol (Baltimore, MD: 1950) 180:438–43.
  • Hammarstrom L, Vorechovsky I, Webster D. (2000). Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 120:225–31.
  • Huang YJ, Lynch SV. (2011). The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respiratory Med 5:809–21.
  • Hurst JR, Elborn JS, De Soyza A. (2015). COPD-bronchiectasis overlap syndrome. Eur Respiratory J 45:310–13.
  • Jorgensen SF, Troseid M, Kummen M, et al. (2016). Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation. Mucosal Immunol. 9:1455–1465.
  • Kainulainen L, Nikoskelainen J, Ruuskanen O. (2001). Diagnostic findings in 95 Finnish patients with common variable immunodeficiency. J Clin Immunol 21:145–9.
  • Kainulainen L, Nikoskelainen J, Vuorinen T, et al. (1999). Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia. Am J Respiratory Critical Care Med 159:1199–204.
  • Kainulainen L, Vuorinen T, Rantakokko-Jalava K, et al. (2010). Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 126:120–6.
  • Kamdar K, Nguyen V, Depaolo RW. (2013). Toll-like receptor signaling and regulation of intestinal immunity. Virulence 4:207–12
  • Kralickova P, Mala E, Vokurkova D, et al. (2014). Cytomegalovirus disease in patients with common variable immunodeficiency: three case reports. Int Arch Allergy Immunol 163:69–74.
  • Kuntz M, Goldacker S, Blum HE, et al. (2011). Analysis of bulk and virus-specific CD8+ T cells reveals advanced differentiation of CD8+ T cells in patients with common variable immunodeficiency. Clin Immunol (Orlando, FL) 141:177–86.
  • Kurth J, Hansmann ML, Rajewsky K, Kuppers R. (2003). Epstein–Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Proc Natl Acad Sci USA 100:4730–5.
  • Kutukculer N, Gulez N, Karaca NE, et al. (2012). Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency. J Clin Immunol 32:1165–79.
  • Lazarus A, Myers J, Fuhrer G. (2008). Bronchiectasis in adults: a review. Postgraduate Med 120:113–21.
  • Lee JJ, Ozcan E, Rauter I, Geha RS. (2008). Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency. Curr Opin Allergy Clin Immunol 8:520–6.
  • Litzman J, Freiberger T, Grimbacher B, et al. (2008). Mannose-binding lectin gene polymorphic variants predispose to the development of bronchopulmonary complications but have no influence on other clinical and laboratory symptoms or signs of common variable immunodeficiency, Clin Exp Immunol 153:324–30.
  • Liu PT, Stenger S, Li H, et al. (2006). Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science (New York, NY) 311:1770–3.
  • Livnat G, Bentur L. (2009). Non-cystic fibrosis bronchiectasis: review and recent advances. F1000 Med Rep 1:9. 10.3410/M1-67.
  • Lobito AA, Gabriel TL, Medema JP, Kimberley FC. (2011). Disease causing mutations in the TNF and TNFR superfamilies: Focus on molecular mechanisms driving disease. Trends Mol Med 17:494–505.
  • Long KZ, Rosado JL, Santos JI, et al. (2010). Associations between mucosal innate and adaptive immune responses and resolution of diarrheal pathogen infections. Infect Immun 78:1221–8.
  • Lopez-Boado YS, Rubin BK. (2008). Macrolides as immunomodulatory medications for the therapy of chronic lung diseases. Curr Opin Pharmacol 8:286–91.
  • Lougaris V, Baronio M, Vitali M, et al. (2012). B cell responses to CpG correlate with CXCL16 expression levels in common variable immunodeficiency. Sci World J 2012:960219.
  • Lucas M, Lee M, Lortan J, et al. (2010). Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol 125:1354–60.e4.
  • Malech HL, Deleo FR, Quinn MT. (2014). The role of neutrophils in the immune system: an overview. Methods Mol Biol (Clifton, NJ) 1124:3–10.
  • Marashi SM, Raeiszadeh M, Enright V, et al. (2012). Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency. J Allergy Clin Immunol 129:1349–56.e3.
  • Marron TU, Yu JE, Cunningham-Rundles C. (2012). Toll-like receptor function in primary B cell defects. Front Biosci (Elite Ed) 4:1853–63.
  • Martini H, Enright V, Perro M, et al. (2011). Importance of B cell co-stimulation in CD4(+) T cell differentiation: X-linked agammaglobulinaemia, a human model. Clin Exp Immunol 164:381–7.
  • Mohammadinejad P, Aghamohammadi A, Abolhassani H, et al. (2012). Pediatric patients with common variable immunodeficiency: long-term follow-up. J Invest Allergol Clin Immunol: Off Organ Int Assoc Asthmol (INTERASMA) Soc Latinoam Alergia Inmunol 22:208–14.
  • Morimoto Y, Routes JM. (2005). Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep 5:370–5.
  • Morris A, Beck JM, Schloss PD, et al. (2013). Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respiratory Crit Care Med 187:1067–75.
  • Oksenhendler E, Gerard L, Fieschi C, et al. (2008). Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 46:1547–54.
  • Ong EL, Ellis ME, Webb AK, et al. (1989). Infective respiratory exacerbations in young adults with cystic fibrosis: role of viruses and atypical microorganisms. Thorax 44:739–42.
  • Orange JS, Grossman WJ, Navickis RJ, Wilkes MM. (2010). Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies. Clin Immunol (Orlando, FL) 137:21–30.
  • Paccani SR, Boncristiano M, Patrussi L, et al. (2005). Defective Vav expression and impaired F-actin reorganization in a subset of patients with common variable immunodeficiency characterized by T-cell defects. Blood 106:626–34.
  • Park JH, Resnick ES, Cunningham-Rundles C. (2011). Perspectives on common variable immune deficiency. Ann NY Acad Sci 1246:41–9.
  • Perreau M, Vigano S, Bellanger F, et al. (2014). Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders. J Exp Med 211:2033–45.
  • Piatosa B, Pac M, Siewiera K, et al. (2013). Common variable immune deficiency in children-clinical characteristics varies depending on defect in peripheral B cell maturation. J Clin Immunol 33:731.
  • Plebani A, Soresina A, Rondelli R, et al. (2002). Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin Immunol (Orlando, FL) 104:221–30.
  • Poodt AE, Driessen GJ, de Klein A, et al. (2009). TACI mutations and disease susceptibility in patients with common variable immunodeficiency. Clin Exp Immunol 156:35–9.
  • Pribble CG, Black PG, Bosso JA, Turner RB. (1990). Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections. J Pediatrics 117:200–4.
  • Rivoisy C, Gerard L, Boutboul D, et al. (2012). Parental consanguinity is associated with a severe phenotype in common variable immunodeficiency. J Clin Immunol 32:98–105.
  • Rooijakkers SH, Rasmussen SL, McGillivray SM, et al. (2010). Human transferrin confers serum resistance against Bacillus anthracis. J Biol Chem 285:27609–13.
  • Rowe SM, Borowitz DS, Burns JL, et al. (2012). Progress in cystic fibrosis and the CF Therapeutics Development Network. Thorax 67:882–90.
  • Sanders LA, Feldman RG, Voorhorst-Ogink MM, et al. (1995). Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect Immun 63:73–81.
  • Sanders LA, van de Winkel JG, Rijkers GT, et al. (1994). Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. The Journal of Infectious Diseases 170:854–61.
  • Sarma JV, Ward PA. (2011). The complement system. Cell and Tissue Research 343:227–35.
  • Sibley CD, Parkins MD, Rabin HR, Surette MG. (2009). The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis. Current Opinion in Investigational Drugs (London, England) 10:787–94.
  • Song WC. (2012). Crosstalk between complement and toll-like receptors. Toxicologic Pathology, 40:174–82.
  • Tan HL, Rosenthal M. (2013). IL-17 in lung disease: friend or foe? Thorax, 68:788–90.
  • Tunney MM, Einarsson GG, Wei L, et al. (2013). Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. American Journal of Respiratory and Critical Care Medicine 187:1118–26.
  • Tunney MM, Klem ER, Fodor AA, et al. (2011). Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis. Thorax 66:579–84.
  • van de Ven AA, de Jong PA, Hoytema van Konijnenburg DP, et al. (2011). Airway and interstitial lung disease are distinct entities in paediatric common variable immunodeficiency. Clinical and Experimental Immunology 165:235–42.
  • van Zeggeren L, van de Ven AA, Terheggen-Lagro SW, et al. (2011). High-resolution computed tomography and pulmonary function in children with common variable immunodeficiency. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology 38:1437–43.
  • van Zelm MC, Smet J, Adams B, et al. (2010). CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency, The. Journal of Clinical Investigation 120:1265–74.
  • Verma N, Grimbacher B, Hurst JR. (2015). Lung disease in primary antibody deficiency. Lancet Respir Med 3:651–60.
  • Vinuesa CG, de Lucas C, Cook MC. (2001). Clinical implications of the specialised B cell response to polysaccharide encapsulated pathogens. Postgraduate Medical Journal 77:562–9.
  • Visentini M, Cagliuso M, Conti V, et al. (2011). Telomere-dependent replicative senescence of B and T cells from patients with type 1a common variable immunodeficiency. European Journal of Immunology 41:854–62.
  • Vultaggio A, Matucci A, D'Elios MM, et al. (2012). Multiorgan infiltration by CD8+ T cells and 1p;16p translocation in a patient with hypogammaglobulinemia and a reduced number of B cells. International Archives of Allergy and Immunology 158:206–10.
  • Warnatz K, Salzer U, Rizzi M, et al. (2009). B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proceedings of the National Academy of Sciences of the United States of America 106:13945–50.
  • Waters V. (2012). New treatments for emerging cystic fibrosis pathogens other than Pseudomonas. Current Pharmaceutical Design 18:696–725.
  • Wehr C, Kivioja T, Schmitt C, et al. (2008). The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111:77–85.
  • Wheat WH, Cool CD, Morimoto Y, et al. (2005). Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. The Journal of Experimental Medicine 202:479–84.
  • Winkelstein JA, Marino MC, Lederman HM, et al. (2006). X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine 85:193–202.
  • Wong GK, Millar D, Penny S, et al. (2016). Accelerated Loss of TCR Repertoire Diversity in Common Variable Immunodeficiency. Journal of Immunology (Baltimore, Md.: 1950) 197:1642–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.